In addition, modulation of MKL/SRF dependent metastasis networks in both breast cancer and melanoma cell lines with our compound highlights the importance of pharmacologic inhibitors of this pathway as potential future therapeutics in cancer biology. The gene discussed is SRF; the disease is cancer.